Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Freemantle

Showing results (91-100 of 174) with videos related to

Pageof 18
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|March 1, 1995
Economics of treatment of depressionN Freemantle, A House, J Mason, et al.
Journal of Psychopharmacology (Oxford, England)|October 4, 2008
Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic reviewR Whale, T Terao, P Cowen, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Is the incidence of upper respiratory tract infection independent of drug treatment in large cohort studies of longer term use drugs?L V Wilton, S N Freemantle, R Martin, et al.
Psychological Medicine|October 12, 2017
Sociodemographic inequalities in the management of depression in adults aged 55 and over: an analysis of English primary care dataK Walters, M Falcaro, N Freemantle, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Nefazodone in community use: the results of prescription-event monitoringF J Mackay, G L Pearce, S N Freemantle, et al.
The Cochrane Database of Systematic Reviews|May 5, 2000
SSRIs versus other antidepressants for depressive disorderJ R Geddes, N Freemantle, J Mason, et al.
BMJ (Clinical Research Ed.)|July 23, 1994
Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicideN Freemantle, A House, F Song, et al.
Thorax|November 3, 1998
Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonistsR M Martin, N R Dunn, S N Freemantle, et al.
JAMA|December 26, 2001
When is it cost-effective to change the behavior of health professionals?J Mason, N Freemantle, I Nazareth, et al.
Diabetes, Obesity & Metabolism|March 5, 2013
A comparison of health-related quality of life (health utility) between insulin degludec and insulin glargine: a meta-analysis of phase 3 trialsN Freemantle, M Evans, T Christensen, et al.
Pageof 18

Showing results (91-100 of 174) with videos related to

Sort By:
Pageof 18
The British Journal of Psychiatry : the Journal of Mental Science|March 1, 1995
Economics of treatment of depressionN Freemantle, A House, J Mason, et al.
Journal of Psychopharmacology (Oxford, England)|October 4, 2008
Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic reviewR Whale, T Terao, P Cowen, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Is the incidence of upper respiratory tract infection independent of drug treatment in large cohort studies of longer term use drugs?L V Wilton, S N Freemantle, R Martin, et al.
Psychological Medicine|October 12, 2017
Sociodemographic inequalities in the management of depression in adults aged 55 and over: an analysis of English primary care dataK Walters, M Falcaro, N Freemantle, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Nefazodone in community use: the results of prescription-event monitoringF J Mackay, G L Pearce, S N Freemantle, et al.
The Cochrane Database of Systematic Reviews|May 5, 2000
SSRIs versus other antidepressants for depressive disorderJ R Geddes, N Freemantle, J Mason, et al.
BMJ (Clinical Research Ed.)|July 23, 1994
Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicideN Freemantle, A House, F Song, et al.
Thorax|November 3, 1998
Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonistsR M Martin, N R Dunn, S N Freemantle, et al.
JAMA|December 26, 2001
When is it cost-effective to change the behavior of health professionals?J Mason, N Freemantle, I Nazareth, et al.
Diabetes, Obesity & Metabolism|March 5, 2013
A comparison of health-related quality of life (health utility) between insulin degludec and insulin glargine: a meta-analysis of phase 3 trialsN Freemantle, M Evans, T Christensen, et al.
Pageof 18